摘要
目的:观察加速康复外科(FTS)对胃癌病人手术后近期临床结局的影响。方法:将106例胃癌病人随机分为对照组(n=53,采用常规围手术期处理方案)和FTS组(n=53,采用加速康复围手术期处理方案)。动态监测比较两组病人术前和术后第1、3、7天血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和C-反应蛋白(CRP)水平。同时记录空腹血糖(FBG)、空腹胰岛素定量(FINS)。根据稳态模式评估法(HOMA)计算胰岛素抵抗指数(HOMA-IR),并比较两组病人术后发热时间、肛门排气时间、住院天数、住院费用和并发症的发生等情况。结果:FTS组病人术后第1和第3天IL-6、TNF-α和lnHOMA-IR明显低于对照组;术后第1、3和第7天,CRP明显低于对照组(P<0.05);FTS组病人术后发热时间、肛门排气时间、住院天数和住院费用明显少于对照组(P<0.05),而术后并发症的发生并未增加(P>0.05)。结论:FTS措施能降低胃癌病人手术后的胰岛素抵抗,减轻应激反应,加速病人的康复。
Objective: To investigate the influence of fast tract surgery on recent clinical outcomes in gastric cancer patients.Methods: 106 patients with gastric cancer receving radical operation were randomly divided into two groups: fast track group and control group.Serum levels of TNF-α,IL-6,CRP and fasting blood glucose(FBG)and fasting insulin(FINS) in 106 patients were assayed preoperatively and on 1st,3rd,7th day postoperatively,and insulin resistance index(HOMA-IR)was calculated using Homeostasis Model Assessment(HOMA)to evaluate insulin sensitivity.The postoperative hospital stay,duration of fever,medical cost,postoperative time of flatus and postoperative complications were recorded respectively.Results: On the postoperative 1st and 3rd day,serum levels of TNF-α,IL-6 and lnHOMA-IR in patients in fast track group were significantly lower than those in patients in control group(all P〈0.05).On the postoperative 1st,3rd and 7th day,serum levels of CRP in patients in fast track group were significantly lower than those in patients in control group(all P〈0.05).The postoperative duration of fever,postoperative time of flatus and postoperative hospital stay and treatment expense in patients in fast track group were also significantly lower than those in control group(all P〈0.05).Patients in fast track group had no more complications than those in non-fast track group(P〉0.05).Conclusion: Fast tract surgery can reduce the incidence and the degree of insulin resistance and lessen stress reaction in gastric cancer patients during perioperative period.
出处
《肠外与肠内营养》
CAS
北大核心
2010年第6期338-340,344,共4页
Parenteral & Enteral Nutrition